Roche tacks on an­oth­er Xofluza in­di­ca­tion as flu sea­son meets pan­dem­ic

Xofluza was her­ald­ed as the first new flu drug in 20 years when it got the FDA OK back in 2018. But even so, Roche saw tough com­pe­ti­tion from cheap­er Tam­i­flu gener­ics that ap­peared to be near­ly as — if not just as — ef­fec­tive.

Now, the phar­ma says the drug al­so can be used to pre­vent in­fluen­za af­ter ex­po­sure, snag­ging a new ap­proval and adding to Xofluza’s ap­peal as flu sea­son meets the pan­dem­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER